Stratos Wealth Partners LTD. Sells 544 Shares of iShares Biotechnology ETF $IBB

Stratos Wealth Partners LTD. reduced its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 7.8% in the second quarter, Holdings Channel.com reports. The institutional investor owned 6,391 shares of the financial services provider’s stock after selling 544 shares during the period. Stratos Wealth Partners LTD.’s holdings in iShares Biotechnology ETF were worth $809,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also bought and sold shares of IBB. Ramirez Asset Management Inc. purchased a new position in shares of iShares Biotechnology ETF during the 1st quarter worth approximately $26,000. Berkshire Money Management Inc. bought a new stake in shares of iShares Biotechnology ETF during the second quarter valued at approximately $28,000. Financial Gravity Asset Management Inc. purchased a new stake in iShares Biotechnology ETF in the first quarter worth $30,000. Woodside Wealth Management LLC bought a new position in iShares Biotechnology ETF in the first quarter worth $31,000. Finally, Harbor Asset Planning Inc. purchased a new position in iShares Biotechnology ETF during the second quarter valued at $31,000. 62.45% of the stock is currently owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Stock Performance

Shares of IBB stock opened at $153.92 on Thursday. The company’s fifty day moving average price is $144.20 and its 200-day moving average price is $132.09. iShares Biotechnology ETF has a 12 month low of $107.43 and a 12 month high of $157.19.

iShares Biotechnology ETF Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, September 19th. Shareholders of record on Tuesday, September 16th were issued a $0.0828 dividend. This represents a $0.33 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date was Tuesday, September 16th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.